Comparative Efficacy and Safety if Intravesical Botulinum Toxin A Versus Platelet-Rich Plasma in the Management of Refractory Overactive Bladder : A 2 Year Study

NCT07693192 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Overactive Bladder

Interventions

PROCEDURE: Intravesical Botulinum Toxin A (100U)
PROCEDURE: Intravesical Platelet-Rich Plasma

Sponsor

Mahmoud Mohamed Farag Ali